Foxx Life Sciences

Foxx Life Sciences, founded in 2013 and headquartered in Salem, New Hampshire, is a private company providing essential single-use technologies (SUT) and lab consumables to the biopharma industry. It operates as a specialized manufacturer and distributor, offering a broad range of standard and custom-made assemblies for bioprocessing, focusing on components like sterile bottle assemblies, caps, gaskets, filters, and connectors. The company's business model is service-oriented, supplying tools for drug delivery and diagnostics workflows, and it is firmly in a revenue-generating, commercial stage by selling physical products to biotech and research customers.

Integrated design and manufacturing capability for custom single-use bioprocess assemblies, encompassing fluid transfer, filtration, and containment components with a focus on material compatibility and regulatory compliance.

Foxx operates in a highly competitive market dominated by global giants like Thermo Fisher Scientific, Danaher (Cytiva), and Merck Millipore. It differentiates itself as a nimble, specialist provider of custom single-use assemblies, competing on tailored solutions, service, and potentially price against the broader but sometimes less flexible portfolios of the major players.